What is United Therapeutics's tyvaso dpi — loss related to commercial supply agreement?

United Therapeutics (UTHR) reported tyvaso dpi — loss related to commercial supply agreement of $26.80M in Q1 2026.

Products & Services · Loss related to commercial supply agreement

Tyvaso DPI — Loss related to commercial supply agreement

Analysis

StatementSegment

CategoryRisk

SignalLower is better

VolatilityVolatile

First reportedQ1 2026

Last reportedQ1 2026

How to read this metric

An increase signals operational friction or unfavorable supply chain contracts, while a decrease indicates improved supply chain stability and contract management.

Detailed definition

Captures financial losses or charges incurred due to contractual obligations or unfavorable terms within a commercial su...

Peer comparison

Specific to companies with complex third-party manufacturing or supply chain partnerships.

Metric ID: uthr_segment_tyvaso_dpi_loss_related_to_commercial_supply_agreement

Historical Data

1 periods

	Q1 '26
Value	$26.80M

Similar Metrics at Other Companies

DuPont de Nemours, Inc.DD View metric

InsmedINSM View metric

ViatrisVTRS View metric

DuPont de Nemours, Inc.DD View metric

VeraltoVLTO View metric

Frequently Asked Questions

What is United Therapeutics's tyvaso dpi — loss related to commercial supply agreement?: United Therapeutics (UTHR) reported tyvaso dpi — loss related to commercial supply agreement of $26.80M in Q1 2026.
What does tyvaso dpi — loss related to commercial supply agreement mean?: Financial losses resulting from contractual supply obligations or manufacturing agreements.